期刊文献+

胆管细胞雌激素受体与原发性胆汁性肝硬化进展的关系

Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis
下载PDF
导出
摘要 Estrogen receptors (ER) in cholangiocytes of primary biliary cirrhosis (PBC) patients and their relationship with cell proliferation and death were evaluated. Liver biopsies from PBC patients with different histological stages were investigated by immunohistochemistry for ER-αand -β, cytokeratin-19, proliferating cellular nuclear antigen (PCNA), Fas and terminal deoxynucleotide transferase end labelling (TUNEL). Normal livers and livers from primary sclerosing cholangitis and alcoholic cirrhosis were investigated as controls. ER-αand -βwere observed in cholangiocytes of PBC patients but not in normal liver. In PBC, positivity for ER-βwas high (50-65%) in all histological stages while, positivity for ER-αincreased from 1%in stage I to 12%in stage III (positivity correlated and colocalized in the same cell with PCNA). In stage IV of PBC, cholangiocytes were negative for ER-αin association with a lower PCNA positivity and with maximal degree of ductopenia. ER-αpositivity in cholangiocytes of PBC patients was markedly lower than primary sclerosing cholangitis and alcoholic cirrhosis. ER are expressed in PBC and other pathologies associated with cholangiocyte proliferation but not in normal subjects. The low expression of ER-αin PBC and their disappearance in the advanced histological stages suggests that an estrogenic deficiency could favour the evolution of this disease toward ductopenia. Estrogen receptors (ER) in cholangiocytes of primary biliary cirrhosis (PBC) patients and their relationship with cell proliferation and death were evaluated. Liver biopsies from PBC patients with different histological stages were investigated by immunohistochemistry for ER-αand -β, cytokeratin-19, proliferating cellular nuclear antigen (PCNA), Fas and terminal deoxynucleotide transferase end labelling (TUNEL). Normal livers and livers from primary sclerosing cholangitis and alcoholic cirrhosis were investigated as controls. ER-αand -βwere observed in cholangiocytes of PBC patients but not in normal liver. In PBC, positivity for ER-βwas high (50-65%) in all histological stages while, positivity for ER-αincreased from 1%in stage I to 12%in stage III (positivity correlated and colocalized in the same cell with PCNA). In stage IV of PBC, cholangiocytes were negative for ER-αin association with a lower PCNA positivity and with maximal degree of ductopenia. ER-αpositivity in cholangiocytes of PBC patients was markedly lower than primary sclerosing cholangitis and alcoholic cirrhosis. ER are expressed in PBC and other pathologies associated with cholangiocyte proliferation but not in normal subjects. The low expression of ER-αin PBC and their disappearance in the advanced histological stages suggests that an estrogenic deficiency could favour the evolution of this disease toward ductopenia.
出处 《世界核心医学期刊文摘(胃肠病学分册)》 2005年第5期51-52,共2页 Core Journals in Gastroenterology
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部